DeepC Research Agents: AI Co-Scientists for Formulation Development

Product Description

Specialist AI agents that do formulation development work, end to end. Describe the problem in plain language; DeepC plans the work, routes it to the right specialists and returns decision-ready deliverables in minutes: complete development assessments, excipient selection justified against precedent and the FDA IID, QTPPs and design spaces, deformulation of reference products, multi-objective formulation optimization, freedom-to-operate opinions with drafted patent applications, process design, and statistical analysis of your own experimental data. Every claim is anchored to primary sources across FDA, EMA, MHRA, PMDA, ANVISA, Health Canada, TGA, WHO and Swissmedic documents, patents, excipient data and clinical trials. Validated with leading pharmaceutical companies. We know your IP is everything. So is keeping it yours: single-tenant VPC, customer-managed encryption, 21 CFR Part 11-aligned audit log. Your data is never used to train our models. deepceutix.com

DeepCeutix

  • Country/Region:
    United Kingdom
  • Founded:
    2025
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Start-up
Primary activities
Technology
Specifications
  • Details
    Specifications
    • Specialist agents: Research, Formulation, Deformulation, Optimization, FTO, Patent Drafting, VCM Process Design, Analytics
    • Decision-ready deliverables in minutes, every claim cited to a primary source
    • Anchored to FDA IID, Drugs@FDA, DailyMed, GRAS, EMA EPAR, ClinicalTrials.gov, PubMed, PubChem and the global pharma patent corpus
    • ICH Q8(R2) and CTD 3.2.P.2 structure; web app and desktop app; upload your own documents; Python analytics sandbox
    Application areas
    • Oral solid dose, amorphous solid dispersions (HME, spray drying), lipid-based and parenteral forms
    • Generics deformulation and Q1/Q2 estimation; 505(b)(2) reformulation
    • Excipient selection against IID precedent; QbD (QTPP, CQAs, design space)
    • Freedom-to-operate and patent drafting; process design; analysis of your experimental data
  • Selling Points
    Convenience; Product Features; Product Performance; Quality Service;
    • Decision-ready deliverables in minutes, not raw search results
    • Every claim cited to a primary source
    • Small molecule, generics and NCE programmes
    • Runs on your own experimental data
    • Audit trail aligned to 21 CFR Part 11
    • Live demos at CPHI Milan 2026, Hall 8, stand 8S72, 6 to 8 October
    • deepceutix.com
  • Supplied from
    United Kingdom

DeepCeutix

  • Country/Region:
    United Kingdom
  • Founded:
    2025
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Start-up
Primary activities
Technology

More Products from DeepCeutix (2)

  • DeepC Biologics Agents: Biologic Formulation and CMC

    Product DeepC Biologics Agents: Biologic Formulation and CMC

    Specialist AI agents that do biologics formulation and CMC work across antibodies, ADCs, bispecifics, mRNA-LNP, AAV and cell therapy. Give DeepC a molecule, sequence or program and get decision-ready deliverables in minutes: biologic formulation strategies with excipient and buffer selection justified by a...
  • DeepC Safety Agents: PDE, OEL, E&L and Nitrosamine Assessments

    Product DeepC Safety Agents: PDE, OEL, E&L and Nitrosamine Assessments

    Produce dossier-ready safety assessments in minutes. Specialist agents cover permitted daily exposure (PDE/ADE) monographs, occupational exposure limits (OEL), extractables and leachables risk assessments, nitrosamine risk evaluation and environmental risk assessment (ERA), each anchored to ICH, EMA, FDA a...